Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium citrate
Drug ID BADD_D02522
Description Not Available
Indications and Usage Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment.
Marketing Status Not Available
ATC Code N05AN01
DrugBank ID DB14507
KEGG ID D04749
MeSH ID C070669
PubChem ID 13520
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms lithium citrate | Litarex | monolithium citrate
Chemical Information
Molecular Formula C6H5Li3O7
CAS Registry Number 919-16-4
SMILES [Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Unresponsive to stimuli17.02.05.031-Not Available
Urinary incontinence20.02.02.010; 17.05.01.008-
Urticaria23.04.02.001; 10.01.06.001--
Ventricular septal defect03.07.02.001; 02.04.02.007-Not Available
Vertigo04.04.01.003; 17.02.12.002--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003-
Water intoxication19.07.03.004; 14.05.06.004; 05.03.03.003-Not Available
Weight decreased13.15.01.005--
Weight increased13.15.01.006-
Wheezing22.03.01.009-
White blood cell count decreased13.01.06.012--
White blood cell count increased13.01.06.013--Not Available
Withdrawal syndrome08.06.02.012; 19.07.02.005-Not Available
Mental status changes19.07.01.001-Not Available
Tubulointerstitial nephritis20.05.02.002-Not Available
Psychomotor skills impaired19.22.01.002; 17.02.10.005-Not Available
Left ventricular dysfunction02.04.02.011-
Balance disorder17.02.02.007-Not Available
Bradyphrenia19.10.03.002; 17.03.03.004-Not Available
Congenital hydronephrosis20.01.05.002; 03.06.02.001-Not Available
Self-injurious ideation19.12.01.007-Not Available
Haemodynamic instability24.03.02.006-Not Available
Nerve injury17.02.10.007; 12.01.12.002-Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Electrocardiogram PR prolongation13.14.05.012-Not Available
Affect lability19.04.01.001-Not Available
Transaminases increased13.03.01.015-Not Available
Dysphemia17.02.08.010; 19.19.03.005-Not Available
Congestive cardiomyopathy02.04.01.003-Not Available
The 8th Page    First    Pre   8 9 10    Next   Last    Total 10 Pages